Advansource Biomaterials Corp (ASNB) financial statements (2021 and earlier)

Company profile

Business Address 229 ANDOVER STREET
WILMINGTON, MA 01887
State of Incorp. DE
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
3/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0000000
Cash and cash equivalents0000000
Receivables0     0
Inventory, net of allowances, customer advances and progress billings0000000
Inventory0000000
Prepaid expense0     
Deferred costs    000
Prepaid expense and other current assets0
Other undisclosed current assets0100000
Total current assets:0101111
Noncurrent Assets
Property, plant and equipment0222222
Deposits noncurrent assets0      
Other undisclosed noncurrent assets0000000
Total noncurrent assets:0222222
TOTAL ASSETS:0323333
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities0      
Accounts payable0      
Accrued liabilities0      
Customer advances and deposits0000
Other undisclosed current liabilities0110110
Total current liabilities:0111110
Noncurrent Liabilities
Liabilities, other than long-term debt   00  
Accounts payable and accrued liabilities   00  
Other undisclosed noncurrent liabilities0222222
Total noncurrent liabilities:0222222
Total liabilities:0333332
Stockholders' equity
Stockholders' equity attributable to parent, including:(0)(1)(1)(0)(0)01
Common stock0000000
Treasury stock, value 000000
Additional paid in capital0383838383838
Accumulated deficit(0)(39)(39)(38)(38)(38)(37)
Other undisclosed stockholders' equity attributable to parent (0)(0)(0)(0)(0)(0)
Other undisclosed stockholders' equity(0)      
Total stockholders' equity:(0)(1)(1)(0)(0)01
TOTAL LIABILITIES AND EQUITY:0323333

Income statement (P&L) ($ in millions)

3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
3/31/2013
Revenues032 332
Revenue, net32 332
Cost of revenue
(Cost of Goods and Services Sold)
(0)(1)(1)(85)(1)(1)(1)
Gross profit:021(85)221
Operating expenses(0)(2)(2)(310)(2)(2)(2)
Other operating expense, net
(Other Expenses)
    (0)(0) 
Operating income (loss):00(0)(395)(0)(1)(1)
Nonoperating income
(Investment Income, Nonoperating)
0      
Interest and debt expense (0)(0) (0)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:0(0)(1)(395)(1)(1)(1)
Other undisclosed loss from continuing operations before income taxes(0)      
Net income (loss):0(0)(1)(395)(1)(1)(1)
Other undisclosed net income attributable to parent   39500 
Net income (loss) available to common stockholders, diluted:0(0)(1)0(0)(1)(1)

Comprehensive Income ($ in millions)

3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
3/31/2013
Net income (loss):0(0)(1)(395)(1)(1)(1)
Comprehensive income (loss), net of tax, attributable to parent:0(0)(1)(395)(1)(1)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: